Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma

Clinical trial NCT02101905 · COMPLETED

Trial details

NCT number: NCT02101905
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Anaplastic Astrocytoma Anaplastic Ependymoma Anaplastic Oligodendroglioma Gliosarcoma Mixed Glioma Recurrent Adult Brain Neoplasm Recurrent Glioblastoma

Start date: 2016-11-07
Primary completion: 2021-10-19
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.